Market Overview:
The global oral antibiotics market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of infectious diseases, rising demand for oral antibiotics due to their ease of use, and growing awareness about the benefits of early diagnosis and treatment. Based on type, the global oral antibiotics market is segmented into beta lactam and beta lactamase inhibitors, quinolone, macrolide, tetracycline & fluoroquinolones (T&F), and others. Beta lactams are expected to account for the largest share of the global oral antibiotics market in 2018 owing to their high efficacy against a wide range of bacteria. Quinolones are also expected to witness significant growth during the forecast period due to their ability to treat serious infections caused by multidrug-resistant bacteria.
Product Definition:
Oral antibiotics are a type of medication that is taken by mouth. They are used to treat infections caused by bacteria. Oral antibiotics are important because they can help to cure an infection quickly.
Beta Lactam and Beta Lactamase Inhibitors:
Beta lactam is a group of antibiotics that are produced by certain bacteria. The most commonly used beta lactams are oxazolidinones, such as nafcillin and oxazolidinediones, which have the ability to inhibit Penicillin-Gram-Positive (PBP) bacteria.
Quinolone:
Quinolone is a type of antibiotic that was first discovered in the late 19th century. It has been used as an oral drug to treat gonorrhea and chlamydia since the early 20th century. However, it has recently gained popularity as an anti-fungal medication due to its ability to inhibit fungal growth.
Application Insights:
The application segment includes respiratory tract infection, dental therapy, urinary tract infection and others. The respiratory tract infections (RTIs) segment dominated the global market in terms of revenue share in 2017. This is due to the increasing prevalence of RTIs such as asthma and bronchitis across the globe. According to a WHO study, over 300 million people suffer from chronic bronchitis worldwide which contributes towards a significant share of revenue for this segment every year.
In addition, according to an article published by NCBI in 2018 regarding antibiotic usage patterns against different types of RTIs, beta lactam antibiotics are predominantly used for treating acute rhinosinusitis with or without nasal congestion along with acute sinusitis without nasal congestion along with acute sinonasal disease associated symptoms including facial pain ear pain and headache among other conditions like bacterial pneumonia etcetera globally as well as within North America region specifically U.S.
Regional Analysis:
Asia Pacific dominated the global market in 2017, accounting for a share of over 45.0% owing to high prevalence of infectious diseases and rising healthcare expenditure in this region. The presence of key pharmaceutical companies such as WOCKHARDT, Shire, GSK, Cipla and Sun Pharmaceutical is also expected to boost the growth over the forecast period. In addition, increasing number of antibiotic resistant infections is another factor boosting regional market growth. According to WHO data published in October 2018; nearly 23 million people across 28 countries were infected with drug-resistant bacteria that are common pathogens responsible for respiratory tract infections or tuberculosis (TB).
In terms of revenue generated by individual countries within Asia Pacific region; Japan leads with a share close to 30%.
Growth Factors:
- Increasing incidence of infectious diseases: The global incidence of infectious diseases is increasing every year, which is driving the demand for oral antibiotics.
- Growing awareness about oral hygiene: There is a growing awareness among people about the importance of oral hygiene, which is propelling the growth of the oral antibiotics market.
- Rising prevalence of dental caries and other dental disorders: The prevalence of dental caries and other dental disorders is rising globally, which is leading to an increase in demand for oral antibiotics.
- Increasing number of surgical procedures: The number of surgical procedures being performed globally is increasing rapidly, resulting in an increase in demand for oral antibiotics prophylaxis and treatment regimens. 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Antibiotics Market Research Report
By Type
Beta Lactam and Beta Lactamase Inhibitors, Quinolone, Macrolide
By Application
Respiratory Tract Infection, Dental Therapy
By Companies
Abbott Laboratories, Allergan, F.Hoffmann-La Roche, GlaxoSmithKline, Merck and Corporation, Mylan, Novartis, Pfizer, Sanofi, Teva Pharmaceutical Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Oral Antibiotics Market Report Segments:
The global Oral Antibiotics market is segmented on the basis of:
Types
Beta Lactam and Beta Lactamase Inhibitors, Quinolone, Macrolide
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Respiratory Tract Infection, Dental Therapy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Allergan
- F.Hoffmann-La Roche
- GlaxoSmithKline
- Merck and Corporation
- Mylan
- Novartis
- Pfizer
- Sanofi
- Teva Pharmaceutical Industries
Highlights of The Oral Antibiotics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Beta Lactam and Beta Lactamase Inhibitors
- Quinolone
- Macrolide
- By Application:
- Respiratory Tract Infection
- Dental Therapy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Antibiotics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral antibiotics are medications that are taken by mouth. They are used to treat a variety of infections, including bronchitis, pneumonia, and ear infection.
Some of the major companies in the oral antibiotics market are Abbott Laboratories, Allergan, F.Hoffmann-La Roche, GlaxoSmithKline, Merck and Corporation, Mylan, Novartis, Pfizer, Sanofi, Teva Pharmaceutical Industries.
The oral antibiotics market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oral Antibiotics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oral Antibiotics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oral Antibiotics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oral Antibiotics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oral Antibiotics Market Size & Forecast, 2020-2028
4.5.1 Oral Antibiotics Market Size and Y-o-Y Growth
4.5.2 Oral Antibiotics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Beta Lactam and Beta Lactamase Inhibitors
5.2.2 Quinolone
5.2.3 Macrolide
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Respiratory Tract Infection
6.2.2 Dental Therapy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oral Antibiotics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oral Antibiotics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Beta Lactam and Beta Lactamase Inhibitors
9.6.2 Quinolone
9.6.3 Macrolide
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Respiratory Tract Infection
9.10.2 Dental Therapy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Beta Lactam and Beta Lactamase Inhibitors
10.6.2 Quinolone
10.6.3 Macrolide
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Respiratory Tract Infection
10.10.2 Dental Therapy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Beta Lactam and Beta Lactamase Inhibitors
11.6.2 Quinolone
11.6.3 Macrolide
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Respiratory Tract Infection
11.10.2 Dental Therapy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Beta Lactam and Beta Lactamase Inhibitors
12.6.2 Quinolone
12.6.3 Macrolide
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Respiratory Tract Infection
12.10.2 Dental Therapy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Beta Lactam and Beta Lactamase Inhibitors
13.6.2 Quinolone
13.6.3 Macrolide
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Respiratory Tract Infection
13.10.2 Dental Therapy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oral Antibiotics Market: Competitive Dashboard
14.2 Global Oral Antibiotics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Allergan
14.3.3 F.Hoffmann-La Roche
14.3.4 GlaxoSmithKline
14.3.5 Merck and Corporation
14.3.6 Mylan
14.3.7 Novartis
14.3.8 Pfizer
14.3.9 Sanofi
14.3.10 Teva Pharmaceutical Industries
